Shaylen Foley

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Cervical Cancer Screening

Health Insurance

Transcranial Direct Current Stimulation

Top Venues

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shaylen Foley, Ashleigh Flowers, Tralisa Hall, Matthew T Jansen, Michelle Burcin
"That Was an Eye Opener for Me": Mixed-Methods Outcomes Educating Texas Community Health Workers on HPV Vaccination Using Project ECHO ® . Vaccines 12 (7) (2024)
Shaylen Foley, Ashleigh Flowers, Tralisa Hall, Matthew T Jansen, Michelle Burcin
"That Was an Eye Opener for Me": Mixed-Methods Outcomes Educating Texas Community Health Workers on HPV Vaccination Using Project ECHO ® . Vaccines 12 (7) (2024)
Shaylen Foley, Ashleigh Flowers, Tralisa Hall, Matthew T Jansen, Michelle Burcin
"That Was an Eye Opener for Me": Mixed-Methods Outcomes Educating Texas Community Health Workers on HPV Vaccination Using Project ECHO ® . Vaccines 12 (7) (2024)
Shaylen Foley, Jennifer Nkonga, Marcie Fisher-Borne
Engaging health plans to prioritize HPV vaccination and initiate at age 9. Human vaccines & immunotherapeutics 19 (1) (2023)
Shaylen Foley, Jennifer Nkonga, Marcie Fisher-Borne
Engaging health plans to prioritize HPV vaccination and initiate at age 9. Human vaccines & immunotherapeutics (2023)
Shaylen Foley, Jennifer Nkonga, Marcie Fisher-Borne
Engaging health plans to prioritize HPV vaccination and initiate at age 9. Human vaccines & immunotherapeutics 19 (1) (2023)
Shaylen Foley, Jennifer Nkonga, Marcie Fisher-Borne
Engaging health plans to prioritize HPV vaccination and initiate at age 9. Human vaccines & immunotherapeutics 19 (1) (2023)
Shaylen Foley, Jennifer Nkonga, Marcie Fisher-Borne
Engaging health plans to prioritize HPV vaccination and initiate at age 9. Human vaccines & immunotherapeutics 19 (1) (2023)
Shaylen Foley, Jennifer Nkonga, Marcie Fisher-Borne
Engaging health plans to prioritize HPV vaccination and initiate at age 9. Human vaccines & immunotherapeutics 19 (1) (2023)